首页> 外文期刊>Neuropsychologia >Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease
【24h】

Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease

机译:多巴胺能药物对帕金森氏病基本运动表现和执行功能的差异作用

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Patients with Parkinson's disease (PD) often show deficits in the self-initiation and selection of movements, which can be partly compensated for by external cues. We here investigated impairments in the initiation and selection of self-initiated or externally cued movements in PD. Specifically, we assessed how behavioral changes relate to medication, disease severity, and basic motor or cognitive deficits. Methods: Seventeen akinetic-rigid PD patients and 16 healthy controls (HC) performed a computerized motor task assessing differences between internally and externally triggered movements and reaction times. Patients performed the task twice in a randomized fashion, once with their regular dopaminergic medication and once 12. h after withdrawal of medication. Additionally, all subjects underwent comprehensive neuropsychological and motor assessments. Results: Compared to HC, patients showed a significant slowing across all tasks. Furthermore, patients showed a selective deficit of movement initiation as indexed by longer reaction times when movement lateralization was internally chosen as opposed to being externally cued. This deficit correlated significantly with motor scores of the Unified Parkinson's Disease Rating Scale (UPDRS). Notably, there was no main effect of dopaminergic medication ("ON"/"OFF") on internally and externally triggered movements despite significant improvement of UPDRS and maximum finger tapping frequency in the "ON" state. Discussion: Our results suggest that disease severity in PD patients is related to disturbances in internal action initiation, selection and simple decision processes. Moreover, the data add further support to the notion that dopaminergic medication differentially affects motor and cognitive performance in PD. These findings imply that disturbances in executive functions in PD are also influenced by factors other than reduced dopaminergic activity.
机译:背景:帕金森氏病(PD)的患者经常表现出自我启动和运动选择方面的缺陷,部分可以通过外部提示来弥补。我们在这里调查了PD中自发或外部提示运动的启动和选择中的障碍。具体来说,我们评估了行为改变与药物治疗,疾病严重程度以及基本运动或认知缺陷之间的关系。方法:17名运动僵硬的PD患者和16名健康对照(HC)执行了计算机化的运动任务,评估了内部和外部触发的运动和反应时间之间的差异。患者以随机方式执行了两次任务,一次使用常规的多巴胺能药物,一次在停药后12小时。此外,所有受试者均接受了全面的神经心理学和运动评估。结果:与HC相比,患者在所有任务中均表现出明显的减慢。此外,患者表现出选择性的运动启动缺陷,这是通过在内部选择运动侧化而不是从外部进行提示时更长的反应时间来确定的。该缺陷与帕金森病综合评分量表(UPDRS)的运动评分显着相关。值得注意的是,尽管UPDRS显着改善并且在“ ON”状态下最大的手指敲击频率,多巴胺能药物(“ ON” /“ OFF”)对内部和外部触发的运动没有主要作用。讨论:我们的结果表明,PD患者的疾病严重程度与内部动作启动,选择和简单决策过程的紊乱有关。此外,数据进一步支持了多巴胺能药物差异性影响PD运动和认知表现的观点。这些发现暗示PD中执行功能的紊乱也受到多巴胺能活性降低以外的因素的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号